Twenty years of therapy for HIV-1 infection

被引：207

作者：

Pomerantz, RJ ^{[1
]}

Horn, DL ^{[1
]}

机构：

[1] Thomas Jefferson Univ, Jefferson Med Coll, Dept Med, Ctr Human Virol & Biodef,Div Infect Dis & Environ, Philadelphia, PA 19107 USA

来源：

NATURE MEDICINE | 2003年 / 9卷 / 07期

关键词：

D O I：

10.1038/nm0703-867

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Antiretroviral therapy, where available, has transformed HIV-1 disease into a treatable and somewhat chronic infection. This article summarizes the accomplishments thus far and what lies ahead in our struggle to improve the treatment of, and possibly eliminate, HIV-1 infection.

引用

收藏

页码：867 / 873

页数：7

相关论文

共 87 条

[1] Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by a two-amino-acid insertion in HIV-1 Vif from a nonprogressing mother and child [J].

Alexander, L ;

Aquino-DeJesus, MJ ;

Chan, M ;

Andiman, WA .

JOURNAL OF VIROLOGY, 2002, 76 (20) :10533-10539

[2] Positive effects of combined antiretroviral therapy on CD4(+) T cell homeostasis and function in advanced HIV disease [J].

Autran, B ;

Carcelain, G ;

Li, TS ;

Blanc, C ;

Mathez, D ;

Tubiana, R ;

Katlama, C ;

Debre, P ;

Leibowitch, J .

SCIENCE, 1997, 277 (5322) :112-116

[3] A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity [J].

Baba, M ;

Nishimura, O ;

Kanzaki, N ;

Okamoto, M ;

Sawada, H ;

Iizawa, Y ;

Shiraishi, M ;

Aramaki, Y ;

Okonogi, K ;

Ogawa, Y ;

Meguro, K ;

Fujino, M .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (10) :5698-5703

[4] Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population [J].

Bangsberg, DR ;

Hecht, FM ;

Charlebois, ED ;

Zolopa, AR ;

Holodniy, M ;

Sheiner, L ;

Bamberger, JD ;

Chesney, MA ;

Moss, A .

AIDS, 2000, 14 (04) :357-366

[5] Non-adherence to highly active antiretroviral therapy predicts progression to AIDS [J].

Bangsberg, DR ;

Perry, S ;

Charlebois, ED ;

Clark, RA ;

Roberston, M ;

Zolopa, AR ;

Moss, A .

AIDS, 2001, 15 (09) :1181-1183

[6] ISOLATION OF A T-LYMPHOTROPIC RETROVIRUS FROM A PATIENT AT RISK FOR ACQUIRED IMMUNE-DEFICIENCY SYNDROME (AIDS) [J].

BARRESINOUSSI, F ;

CHERMANN, JC ;

REY, F ;

NUGEYRE, MT ;

CHAMARET, S ;

GRUEST, J ;

DAUGUET, C ;

AXLERBLIN, C ;

VEZINETBRUN, F ;

ROUZIOUX, C ;

ROZENBAUM, W ;

MONTAGNIER, L .

SCIENCE, 1983, 220 (4599) :868-871

[7] A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy [J].

Baxter, JD ;

Mayers, DL ;

Wentworth, DN ;

Neaton, JD ;

Hoover, ML ;

Winters, MA ;

Mannheimer, SB ;

Thompson, MA ;

Abrams, DI ;

Brizz, BJ ;

Ioannidis, JPA ;

Merigan, TC .

AIDS, 2000, 14 (09) :F83-F93

[8] The care of HIV-infected adults in the United States [J].

Bozzette, SA ;

Berry, SH ;

Duan, NJ ;

Frankel, MR ;

Leibowitz, AA ;

Lefkowitz, D ;

Emmons, CA ;

Senterfitt, JW ;

Berk, ML ;

Morton, SC ;

Shapiro, MF .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (26) :1897-1904

[9] Pharmacokinetics of once-daily saquinavir hard-gelatin capsules and Saquinavir soft-gelatin capsules boosted with Ritonavir in HIV-1-infected subjects [J].

Cardiello, PG ;

Monhaphol, T ;

Mahanontharit, A ;

van Heeswijk, RP ;

Burger, D ;

Hill, A ;

Ruxrungtham, K ;

Lange, JM ;

Cooper, DA ;

Phanuphak, P .

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 32 (04) :375-379

[10] Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study [J].

Carr, A ;

Samaras, K ;

Thorisdottir, A ;

Kaufmann, GR ;

Chisholm, DJ ;

Cooper, DA .

LANCET, 1999, 353 (9170) :2093-2099

← 1 2 3 4 5 6 7 8 9 →